Prostatis Group’s Invesco NASDAQ 100 ETF QQQM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
6,998
-189
-3% -$53.5K 0.49% 46
2026
Q1
$1.71M Buy
7,187
+1,480
+26% +$370K 0.44% 55
2025
Q4
$1.44M Buy
5,707
+2,363
+71% +$597K 0.34% 62
2025
Q3
$826K Buy
3,344
+21
+0.6% +$4.95K 0.21% 79
2025
Q2
$755K Buy
3,323
+1,878
+130% +$385K 0.22% 85
2025
Q1
$279K Buy
1,445
+388
+37% +$81.2K 0.09% 126
2024
Q4
$222K Buy
+1,057
New +$220K 0.06% 144

Other funds holding QQQM

Prostatis Group's QQQM Position: Q2 2026 in Review

Prostatis Group reduced its Invesco NASDAQ 100 ETF (QQQM) stake by 2.6% in Q2 2026, selling an estimated $53.5K and leaving 6,998 shares worth $2.12M. The position accounts for 0.49% of the portfolio, ranked #46.

Prostatis Group first reported a position in QQQM in Q4 2024 and has held it in 7 quarters since. 1,356 funds tracked by Wall St. Rank hold QQQM as of Q2 2026.

  • Prostatis Group held 6,998 shares of Invesco NASDAQ 100 ETF worth $2.12M as of Q2 2026.
  • Prostatis Group sold 189 Invesco NASDAQ 100 ETF shares in Q2 2026, an estimated $53.5K.
  • Invesco NASDAQ 100 ETF made up 0.49% of Prostatis Group's portfolio in Q2 2026, its #46 holding.
  • Prostatis Group first reported a position in Invesco NASDAQ 100 ETF in Q4 2024 and has held it in 7 quarters since.
  • 1,356 funds tracked by Wall St. Rank held Invesco NASDAQ 100 ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.